- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04817280
COVID-19 in Polish Ice Swimmers. (ICE)
Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.
The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Dolny Slask
-
Wrocław, Dolny Slask, Pologne, 51-618
- Department of Public Health at Wroclaw Medical University
-
-
Lubuskie
-
Gorzów Wielkopolski, Lubuskie, Pologne, 66-400
- Department of Radiotherapy of Multidisciplinary Provincial Hospital
-
Zielona Góra, Lubuskie, Pologne, 65-031
- Treasury Medical Company
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- ice swimmers
Exclusion Criteria:
- not active ice swimmers
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
Ice Swimmers Group.
No intervention.
Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
|
The intervention is not made in the course of a research study.
Ice swimming has been introduced earlier by a given group.
The group was made up of people who already swim in ice.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Délai: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Délai: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Délai: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Délai: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Délai: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Délai: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
Délai: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
- Directeur d'études: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
- Chaise d'étude: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
- Chercheur principal: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
- Chercheur principal: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Processus pathologiques
- Infections à coronavirus
- Infections à Coronaviridae
- Infections à Nidovirales
- Infections par virus à ARN
- Maladies virales
- Infections
- Infections des voies respiratoires
- Maladies des voies respiratoires
- Pneumonie virale
- Pneumonie
- Maladies pulmonaires
- Attributs de la maladie
- Changements de température corporelle
- Syndrome respiratoire aigu sévère
- COVID-19 [feminine]
- Hypothermie
- Résistance aux maladies
Autres numéros d'identification d'étude
- KB-03/139/2021
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Covid19
-
Ricardo Pereira MestreInstitute of Oncology Research (IOR); Istituto Cantonale di PatologiaComplété
-
Instituto de Investigación Hospital Universitario...Instituto de Salud Carlos III; Spanish Clinical Research Network - SCReNActif, ne recrute pas
-
Inmunova S.A.Hospital Italiano de Buenos Aires; Laboratorio Elea Phoenix S.A.; Hospital de... et autres collaborateursComplété
-
Manchester University NHS Foundation TrustUniversity of ManchesterComplété
-
Rush University Medical CenterHospital Civil de GuadalajaraComplétéCovid19États-Unis, Mexique
-
Evelyne D.TrottierComplété
-
Sinovac Research and Development Co., Ltd.Complété
-
Mabwell (Shanghai) Bioscience Co., Ltd.Shanghai Public Health Clinical CenterComplété
-
Anavasi DiagnosticsPas encore de recrutement
Essais cliniques sur Ice Swimming
-
Philips Clinical & Medical Affairs GlobalActif, ne recrute pasAccident vasculaire cérébral | Fibrillation auriculaire | Maladie de la valve aortique | Défaut septal auriculaire | Foramen ovale perméable | Valvulopathie, Cœur | Maladie de la valve mitrale | Maladie de la valvule tricuspideÉtats-Unis
-
The Cleveland ClinicRecrutementFibrillation auriculaire | Thrombose de l'appendice auriculaire gaucheÉtats-Unis
-
IceCure Medical Ltd.Complété
-
University of Erlangen-Nürnberg Medical SchoolGerman Federal Ministry of Education and Research; University of Erlangen-NürnbergInconnueMal au dos | CommunicationAllemagne
-
IceCure Medical Ltd.Complété
-
ConaviComplété
-
Mayo ClinicComplétéOcclusion de l'appendice auriculaire gaucheÉtats-Unis
-
Liberating Technologies, Inc.Vivonics, Inc.ComplétéAmputation | Prothèse | Utilisateur de prothèse | Moignons d'amputation | Amputés | Difformités des membres inférieurs, congénitalesÉtats-Unis
-
Ruijin HospitalRecrutementLymphome diffus à grandes cellules BChine
-
Centre of Postgraduate Medical EducationRecrutementFibrillation auriculairePologne